Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics
- 30 November 2006
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 112 (2), 405-424
- https://doi.org/10.1016/j.pharmthera.2006.04.008
Abstract
No abstract availableKeywords
This publication has 214 references indexed in Scilit:
- Natural Evolution of a Human Virus-Specific Antibody Gene Repertoire by Somatic Hypermutation Requires Both Hotspot-Directed and Randomly-Directed ProcessesHuman Immunology, 2005
- Marked induction of IL-6, haptoglobin and IFNγ following experimental BRSV infection in young calvesVeterinary Immunology and Immunopathology, 2005
- Control of nonsegmented negative-strand RNA virus replication by siRNAVirus Research, 2004
- Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitisThe Lancet, 2004
- Haplotype mapping of the bronchiolitis susceptibility locus near IL8Human Genetics, 2004
- Increased pulmonary secretion of tumor necrosis factor-α in calves experimentally infected with bovine respiratory syncytial virusVeterinary Immunology and Immunopathology, 2000
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999
- The Appearance of Cell-Bound IgE in Respiratory-Tract Epithelium after Respiratory-Syncytial-Virus InfectionNew England Journal of Medicine, 1980
- The antibody response to primary and secondary infection with respiratory syncytial virus: Kinetics of class-specific responsesThe Journal of Pediatrics, 1980
- Respiratory-Syncytial-Virus Infections, Reinfections and ImmunityNew England Journal of Medicine, 1979